financetom
ZYXI
financetom
/
Healthcare
/
ZYXI
All stocks News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Commodities
Zynex, Inc.ZYXI
USD
- At close
USD
- Until the end
The complete list of US stocks
1D
5D
1M
1Y
5Y
MAX
Overview >
Market Cap
64.08M
Revenue (ttm)
192.35M
Net Income (ttm)
2.99M
Shares Out
30.23M
EPS (ttm)
0.09
PE Ratio
23.31
Forward PE
n/a
Dividend
n/a
Ex-Dividend Date
n/a
Volume
76,003
Open
2.180
Previous Close
2.150
Day's Range
2.030 - 2.175
52-Week Range
1.930 - 12.340
Beta
1.10
Analysts
Buy
Price Target
10.25 (+383.49%)
Earnings Date
Apr 29, 2025
Description >

Zynex, Inc., together with its subsidiaries, designs, manufactures, and markets medical devices to treat chronic and acute pain; and activate and exercise muscles for rehabilitative purposes with electrical stimulation.

The company offers NexWave, a dual channel, multi-modality interferential current, transcutaneous electrical nerve stimulation, and neuromuscular electrical stimulation (NMES) device that is marketed to physicians and therapists by field sales representatives; NeuroMove, an electromyography and electric stimulation technology device; InWave, an electrical stimulation product for the treatment of female urinary incontinence; and E-Wave, an NMES device.

It also supplies private labeled products, including electrodes for the delivery of electrical current to the body, and batteries for use in electrotherapy products.

In addition, the company distributes Comfortrac/Saunders for cervical traction, JetStream for hot/cold therapy, LSO Back Braces for lumbar support, and knee braces for knee support.

Further, it offers Zynex Fluid Monitoring System (CM-1500), a fluid volume monitor, which is a non-invasive medical device for monitoring relative fluid volume changes used in operating and recovery rooms to detect fluid loss during surgery and internal bleeding during recovery; Zynex Wireless Fluid Monitoring System (CM-1600), a noninvasive monitoring device designed to measure relative changes in fluid volume in adult patients; NiCO CO-Oximeter, a laser-based noninvasive co-oximeter; and HemeOx tHb Oximeter, a laser-based total hemoglobin pulse oximeter.

The company provides its products for use in pain management and control; stroke and spinal cord injury rehabilitation; hemodynamic monitoring; and pulse oximetry monitoring.

It sells its products through direct sales force primarily in the United States. Zynex, Inc. was founded in 1996 and is headquartered in Englewood, Colorado.

Latest News >
Cenovus subsidiary fined $1.83 mln for 2018 Canada oil spill
Cenovus subsidiary fined $1.83 mln for 2018 Canada oil spill
Apr 26, 2024
April 26 (Reuters) - A Canadian regulator said on Friday a Cenovus Energy ( CVE ) subsidiary has been fined C$2.5 million ($1.83 million) for its role in the 2018 oil spill off the country's Atlantic Coast. The Canada-Newfoundland and Labrador Offshore Petroleum Board (C-NLOPB) had laid three charges against Husky Oil Operations Ltd for the spill - the largest...
Hess sets May 28 shareholder vote on Chevron buyout
Hess sets May 28 shareholder vote on Chevron buyout
Apr 26, 2024
April 26 (Reuters) - Hess Corp ( HES ) set May 28 for a special meeting of shareholders to vote on Chevron Corp ( CVX ) 's $53 billion buyout offer, the company said in a securities filing on Friday. Chevron ( CVX ) last October offered to acquire Hess Corp ( HES ) in a move to gain a...
Venezuela renews motion to disqualify officer overseeing Citgo parent auction
Venezuela renews motion to disqualify officer overseeing Citgo parent auction
Apr 26, 2024
HOUSTON, April 26 (Reuters) - Lawyers representing Venezuela on Friday re-submitted a request to a federal court to disqualify an officer overseeing an auction of shares in the parent of Houston-based refiner Citgo Petroleum, according to a filing with the U.S. district court, Delaware. The request was made based on his improper advocacy to the United States government in a...
Schwab Charles Insider Sold Shares Worth $413,855, According to a Recent SEC Filing
Schwab Charles Insider Sold Shares Worth $413,855, According to a Recent SEC Filing
Apr 26, 2024
05:27 PM EDT, 04/26/2024 (MT Newswires) -- Peter B. Crawford, CFO, on April 24, 2024, sold 5,481 shares in Schwab Charles (SCHW) for $413,855. Following the Form 4 filing with the SEC, Crawford has control over a total of 60,567 shares of the company, with 60,567 controlled indirectly. SEC Filing: https://www.sec.gov/Archives/edgar/data/316709/000170683524000011/xslF345X03/wk-form4_1714166426.xml ...
Copyright 2023-2025 - www.financetom.com All Rights Reserved